But if I knew how to manage my portfolio safer and smarter than most hedge fund managers, I could realistically grow my wealth.
Patient admissions, revenues on the rise at LifePoint Hospitals
An increase in total patient admissions has led to an annual rise in LifePoint Hospitals’ total revenues, which were up by 10.3% to $3.7 billion in 2013.
LifePoint Hospitals (LPNT) has adopted a four-pronged organic growth strategy to boost its revenues, a key element of which is physician recruitment.
Medicare payment rates to hospitals’ outpatient departments increased by 1.7% in 2014. In 2015, the reimbursement rate will increase by another 2.2%.
Since January 2014, Universal Health Services (UHS) and LifePoint Hospitals have traded higher than HCA Holdings (HCA) and Community Health Systems (CYH).
LifePoint Hospitals’ ambitious acquisition strategy is to buy hospitals in states that are adopting or are thought to be adopting Medicaid expansion.
The payer structure of hospitals is different than that of other service industries. The end consumer only covers a small portion of the costs.
The major hedge funds project that the Affordable Care Act will benefit LifePoint Hospitals and increase the company’s revenues.
LifePoint Hospitals’ geographic strategy is to provide medical and surgical services in mainly non-urban markets.
In 2013, salaries accounted for 47% of LifePoint Hospitals’ (LPNT) operating expenses. A shortage of physicians is contributing to high salary costs.
With 67 hospitals, acquisitions continue to strengthen its position in rural markets, especially where LifePoint Hospitals is the sole healthcare provider.
Chronic disease cases have risen in number. This has made people become more dependent on medications and health supplements.
The pharmaceutical industry functions just like any other industry. Yet, it is far more regulated and capital-intensive than other industries.
There is a web of regulations in the research-intensive, highly dynamic pharmaceutical sector. In fact, the industry regulates the entire drug life cycle.
The US pharmaceutical industry has only two drug distribution channels: prescription and over-the-counter. The US Food and Drug Administration regulates both of these channels.
The global pharmaceutical industry was worth an estimated $1 trillion in 2014. In 2013, global pharmaceutical markets generated revenues of $980.1 billion.
This article discusses the major pharmaceutical ETFs in the US markets.
Universal Health Services (UHS) released its third quarter earnings on October 27, 2014. Its share price declined about 9.7% after the release.
Although the increase in total admissions for behavioral health has been more than the acute care segment, revenue per admission declined for the former segment.
For-profit hospital operators beat analysts’ expectations by a solid margin in 3Q14. However, Universal Health Services (UHS) disappointed Wall Street.
Despite higher revenues, Universal Health Services’ (UHS) operating expenses, as a percentage of revenues, increased from 70.4% in 3Q13 to 77.6% in 3Q14.